Compound ID | 99
Class: Drug efflux pump inhibitor
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Efflux pump inhibitor. Serum-associated antibiotic efflux pump inhibitor |
| Target Pathogen: | Active against Acinetobacter baumannii |
| Combined with other compounds: | Yes |
| Description: | Potentiates antibiotics |
| Institute where first reported: | Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA |
| Year first mentioned: | 2014 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/714079 |
| Citations: |
|
| Patent: | CA2952111C |